NICU-based Interventions To Reduce Maternal Depressive and Anxiety Symptoms: A Meta-analysis
Overview
Affiliations
Context: Parents whose infants are being treated in the NICU are at high risk for depression and anxiety, with negative implications for parenting and infant development.
Objective: We conducted a systematic review and meta-analysis of NICU-based interventions to reduce maternal depressive or anxiety symptoms.
Data Sources: PubMed, Embase, PsychInfo, Cochrane, and CINAHL were searched for relevant studies. Reference lists from selected studies were reviewed.
Study Selection: Inclusion criteria included randomized controlled design, a parent-focused intervention delivered in the NICU, valid maternal depressive or anxiety symptom measures at pre- and postintervention, and publication in a peer-reviewed journal in English.
Data Extraction: Data extraction was conducted independently by 2 coders.
Results: Twelve studies met inclusion criteria for qualitative review; 2 were excluded from quantitative analyses for high risk of bias. Fixed- and random-effects models, with 7 eligible studies assessing depressive symptoms, indicated an effect of -0.16 (95% confidence interval [CI], -0.32 to -0.002; < .05) and, with 8 studies assessing anxiety symptoms, indicated an effect of -0.12 (95% CI, -0.29 to 0.05; = .17). The subset of interventions using cognitive behavioral therapy significantly reduced depressive symptoms (effect, -0.44; 95% CI, -0.77 to -0.11; = .01).
Limitations: The small number and methodological shortcomings of studies limit conclusions regarding intervention effects.
Conclusions: Combined intervention effects significantly reduced maternal depressive but not anxiety symptoms. The evidence is strongest for the impact of cognitive behavioral therapy interventions on maternal depressive symptoms.
Zhu X, Fan L Nurs Open. 2025; 12(2):e70120.
PMID: 39924574 PMC: 11807762. DOI: 10.1002/nop2.70120.
Psychological distress in the neonatal intensive care unit: a meta-review.
van Wyk L, Majiza A, Ely C, Singer L Pediatr Res. 2024; 96(6):1510-1518.
PMID: 39327462 PMC: 11624136. DOI: 10.1038/s41390-024-03599-1.
Sahbudak B, Karabulut B Alpha Psychiatry. 2024; 25(3):344-349.
PMID: 39148595 PMC: 11322731. DOI: 10.5152/alphapsychiatry.2024.231497.
Lazzerini M, Barcala Coutinho do Amaral Gomez D, Azzimonti G, Bua J, Brandao Neto W, Brasili L BMJ Paediatr Open. 2024; 8(Suppl 2).
PMID: 39106992 PMC: 11664376. DOI: 10.1136/bmjpo-2024-002539.
Lazzerini M, Bua J, Vuillard C, Squillaci D, Tumminelli C, Panunzi S BMJ Paediatr Open. 2024; 8(Suppl 2).
PMID: 39103175 PMC: 11664352. DOI: 10.1136/bmjpo-2023-002469.